Form D · Biotechnology

Invitae Corp

San Francisco, CA · CIK 0001501134

Offering snapshot reported Apr 13, 2020 · SEC filing

Reported sold
$19.7M
Offering amount: $19.7M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 1, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 13, 2020Initial$19,679,155No comparison5SEC filing
Apr 13, 2020Initial$52,373,418No comparison58SEC filing
Aug 17, 2017Initial$73,500,000No comparison23SEC filing
Aug 16, 2017Initial$16,083,491No comparison12SEC filing
Jun 15, 2017Initial$6,007,102No comparison22SEC filing
Nov 8, 2012Initial$29,557,113No comparison16SEC filing
Mar 29, 2011Initial$2,299,999No comparison1SEC filing
Sep 15, 2010Initial$3,644,999No comparison10SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-364783

Source: Form D, filed Apr 13, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Eric Aguiar Director
Lee Bendekgey Executive
Michele Cargill Executive
Geoffrey Crouse Director
Sean George Director, Executive
Christine Gorjanc Director
Shelly Guyer Executive
Chitra Nayak Director
Anya Schiess Director
Randal Scott Director, Executive
Richard Tompane Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1400 16 Th Street
San Francisco, CA, 94103